Sign in to continue:

Saturday, July 25th, 2026

EverQuote, Inc. Amends Certificate of Incorporation Following 2026 Annual Stockholder Meeting




EverQuote, Inc. 8-K Filing: Key Shareholder Updates and Amendments

EverQuote, Inc. Announces Key Corporate Governance Changes and Shareholder Votes in Latest 8-K Filing

Date of Report: June 4, 2026

Ticker: EVER

Exchange: The Nasdaq Global Market


Key Highlights from the Report

  • Amendment to Certificate of Incorporation Approved
  • Board of Directors Elected
  • Ratification of Independent Auditor

Details of the Report

1. Amendment to Certificate of Incorporation – Officer Exculpation

At the EverQuote, Inc. 2026 Annual Meeting of Stockholders, shareholders approved a significant amendment to the Company’s Restated Certificate of Incorporation. The amendment introduces exculpation from personal liability for certain officers as permitted by revised Delaware law. This change, now effective following its filing with the Delaware Secretary of State, mirrors protections already available to directors and could have substantial implications for corporate governance and risk management.

What does this mean for shareholders?
The amendment limits the ability to bring personal monetary claims against EverQuote’s officers for certain breaches of fiduciary duty. This move is in line with evolving Delaware law and is designed to attract and retain experienced executives by reducing their potential personal legal exposure. While this shields officers from some lawsuits, it does not eliminate liability for all types of wrongdoing (such as acts of bad faith or breaches of the duty of loyalty).

Potential Price Sensitivity:
The amendment could be price-sensitive as it may affect investor perceptions regarding management accountability and the risk profile of EverQuote. Enhanced officer protection could be viewed positively (supporting talent retention and risk management), but some investors may see it as reducing avenues for redress in the event of management misconduct.

2. Election of Directors

Shareholders elected the following individuals to the Board of Directors to serve until the 2027 Annual Meeting or until their successors are duly elected and qualified:

  • David Blundin
  • Sanju Bansal
  • Paul Deninger
  • Jayme Mendal
  • George Neble
  • John Shields
  • Mira Wilczek

The election results show continued shareholder support for current leadership and strategic direction. This continuity could reassure investors about stability in company management, but no new names or significant board changes were announced.

3. Ratification of Independent Auditor

Shareholders ratified the appointment of PricewaterhouseCoopers LLP as EverQuote’s independent registered public accounting firm for the fiscal year ending December 31, 2026. This routine but important step ensures continued oversight of the company’s financial reporting and controls.

Exhibit Filed

  • Exhibit 3.1: The Certificate of Amendment to the Restated Certificate of Incorporation of EverQuote, Inc. was filed as an exhibit to the 8-K, providing the full legal text of the amendment.

Why This Matters for Investors

  • Changes in Officer Liability: The adoption of officer exculpation aligns EverQuote with the latest Delaware corporate governance trends. Investors should monitor how this may impact management’s decision-making and potential legal risks.
  • Corporate Stability: The re-election of all current directors and auditor ratification signifies continuity in governance and financial oversight.

While the amendment itself may not have an immediate direct impact on EverQuote’s financial performance, changes in corporate governance and officer liability can influence investor confidence and thus share price. The amendment could make the company more attractive to top executive talent and may affect how risk is priced in the stock.


Disclaimer: This news article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with financial advisors before making investment decisions. Share price movements may be influenced by multiple factors, and past performance is not indicative of future results.




View EverQuote, Inc. Historical chart here



Syra Health Corp 2025 10-K/A: Executive Officers, Compensation, Share Ownership, and Audit Details

Syra Health Corp. 10-K/A Report: Key Investor Insights S...

Nuburu, Inc. Enters Agreement to Develop and Invest in SunCubes Laser Arm Technology for Vehicle Integration

Nuburu, Inc. Announces Entry into Material Definitive Agreem...